Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 16;12(26):6001-6003.
doi: 10.12998/wjcc.v12.i26.6001.

T lymphocyte proportion in Alzheimer's disease prognosis

Affiliations

T lymphocyte proportion in Alzheimer's disease prognosis

Matthew Willman et al. World J Clin Cases. .

Abstract

Bai et al investigate the predictive value of T lymphocyte proportion in Alzheimer's disease (AD) prognosis. Through a retrospective study involving 62 AD patients, they found that a decrease in T lymphocyte proportion correlated with a poorer prognosis, as indicated by higher modified Rankin scale scores. While the study highlights the potential of T lymphocyte proportion as a prognostic marker, it suggests the need for larger, multicenter studies to enhance generalizability and validity. Additionally, future research could use cognitive exams when evaluating prognosis and delve into immune mechanisms underlying AD progression. Despite limitations inherent in retrospective designs, Bai et al's work contributes to understanding the immune system's role in AD prognosis, paving the way for further exploration in this under-researched area.

Keywords: Alzheimer's disease; Alzheimer's disease prognosis; Electroencephalogram; Immune cell count; Immune function; Modified rankin scale; T lymphocyte; T lymphocyte proportion.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors declare that they have no conflict of interest.

References

    1. Bai H, Zeng HM, Zhang QF, Hu YZ, Deng FF. Correlative factors of poor prognosis and abnormal cellular immune function in patients with Alzheimer's disease. World J Clin Cases. 2024;12:1063–1075. - PMC - PubMed
    1. Benoit JS, Chan W, Piller L, Doody R. Longitudinal Sensitivity of Alzheimer's Disease Severity Staging. Am J Alzheimers Dis Other Demen. 2020;35:1533317520918719. - PMC - PubMed
    1. Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH. Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer's disease. Neuropsychiatr Dis Treat. 2018;14:2133–2140. - PMC - PubMed
    1. Booth MJ, Kobayashi LC, Janevic MR, Clauw D, Piette JD. No increased risk of Alzheimer's disease among people with immune-mediated inflammatory diseases: findings from a longitudinal cohort study of U.S. older adults. BMC Rheumatol. 2021;5:48. - PMC - PubMed
    1. Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer's disease: a bidirectional Mendelian-randomization study. Int J Epidemiol. 2021;50:829–840. - PubMed

LinkOut - more resources